$EDIT short under 70
已更新
EDIT up +140% over last 3 days. Pullback expected here. Gene editing is a hot topic at the moment, but price is absolutely overextended for company with less than 100M revenue annually. Long term huge long potential. Short term, short biased.
交易結束：目標達成
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。